{"database": "lobbying", "table": "lobbying_activities", "rows": [[2875164, "b8e96f5f-d45c-473c-977f-ad7651d15b9c", "Q3", "RAMPY NORTHRUP LLC", 401103289, "NATURAL PRODUCTS ASSOCIATION", 2022, "third_quarter", "FOO", "FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, S.4661); S.4090, Dietary Supplement Listing Act of 2022; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180).", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2022-10-19T11:26:48-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2875164"], "units": {}, "query_ms": 29.16674898006022, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}